INVO Fertility, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from INVO Fertility, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 113,020% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 98% of Healthcare companies in United States.
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: $81 per $100 of sales comes from others' credit, against $123 from others' credit three years earlier. Less money tied up than 97% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 54% of its market value (net debt). Lower than 92% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-21.9×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 59% of Healthcare companies in United States.
Cash Locked Ratio
−$81Money owed to suppliers is larger than money owed by customers plus stock: $81 per $100 of sales comes from others' credit, against $123 from others' credit three years earlier.
Less money tied up than 97% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$207Sales grew 732% in 3 years, but profit fell: $207 less profit per $100 of extra sales.
Lower than 91% of Healthcare companies in United States.
Asset Productivity Ratio
+732% / +445%In 3 years sales changed by +732% while total assets changed by +445%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-5.5×Operating cash was negative last year, while some debt falls due within a year.
Higher than 58% of Healthcare companies in United States.
Cash Cushion Ratio
−54%Debt, after subtracting cash, equals 54% of its market value (net debt).
Lower than 92% of Healthcare companies in United States.
Tangible Assets Ratio
64%Of every $100 the company owns, $64 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 66% of Healthcare companies in United States.
Tangible Net Worth Ratio
0%Of every $100 of net worth, $0 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 73% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
INVO Fertility, Inc. owes $0.36 for every $1 it owns. INVO Fertility, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
0.0Investors pay $0.0 for every $1 of INVO Fertility, Inc.'s yearly profit, lower than 98% of Healthcare companies in United States.
P/B ratio
0.15The share price is 0.15 times INVO Fertility, Inc.'s book value per share, lower than almost all Healthcare companies in United States.
Market cap
$2 MThe total market value of all of INVO Fertility, Inc.'s shares at today's price (share price × number of shares), smaller than 97% of Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
$16 MWhat INVO Fertility, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$3.58Net worth divided by the number of shares. The share price of $0.53 is 0.1 times this, which is the P/B above.
Return on equity (ROE)
-72.7%INVO Fertility, Inc. lost 72.7% of its shareholders' money over the last year, lower than 62% of Healthcare companies in United States.
Owes vs Owns
0.36×INVO Fertility, Inc. owes $0.36 for every $1 it owns (low), lower than 54% of Healthcare companies in United States.
Dividend yield
NoneINVO Fertility, Inc. does not currently pay a dividend.
Revenue growth
+5%Revenue rose 5% in the year to Dec 2025, and grew 103% a year on average over 3 years.
Profit growth
LossINVO Fertility, Inc. made a loss in each of the last two years.
Profit margin
-340.9%INVO Fertility, Inc. lost $341 for every $100 of revenue.
Interest cover
Not coveredINVO Fertility, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtINVO Fertility, Inc. had $1 M more debt than cash (net debt) at Dec 2025.
Questions
What is INVO Fertility, Inc.'s P/E ratio?
Investors pay $0.0 for every $1 of INVO Fertility, Inc.'s yearly profit, lower than 98% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For INVO Fertility, Inc.: $2 M ÷ $16 M (30 Jun 2026) = 0.1.
What is INVO Fertility, Inc.'s return on equity?
INVO Fertility, Inc. lost 72.7% of its shareholders' money over the last year, lower than 62% of Healthcare companies in United States.
How much does INVO Fertility, Inc. owe compared with what it owns?
INVO Fertility, Inc. owes $0.36 for every $1 it owns (low), lower than 54% of Healthcare companies in United States.
Does INVO Fertility, Inc. pay a dividend?
No. INVO Fertility, Inc. does not currently pay a dividend.
Is INVO Fertility, Inc.'s revenue growing?
Revenue rose 5% in the year to Dec 2025, and grew 103% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.